arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

DEXCOM INC

DXCM
$84.47 ▼ -4.00 (-4.53%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
69 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
87
Health
Excellent
Bullish
auto_awesome

Analytical Summary

DEXCOM INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $31.7B
Dividend Yield —
Revenue Growth 11.2% ↘
Op. Margin 24.3% →
ROIC 10.6% ↗
FCF / Share $0.73 ↗
Trailing P/E 115.7x
Price / Book 12.4x
FCF Yield 0.9%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.34B
↑ +11.2% —
Net Income Profit after all expenses
$275.10M
↓ -3.1% —
Operating Margin Operating profit as % of sales
24.3%
— 0.0% 74th
FCF / Share Free cash flow per share
$0.73
↑ +50.8% —
Long-Term Debt Long-term obligations
$2.90M
↓ -17.1% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
80
Returns ↑
93
Financial Health ↑
94
Cash Quality ↑
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters